This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07916/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07916/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07916/identifier/pubchem-substance/
n8http://bio2rdf.org/drugbank:
n14http://linked.opendata.cz/resource/drugbank/drug/DB07916/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07916/identifier/chemspider/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07916
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07916 n8:DB07916
dcterms:title
3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID
adms:identifier
n10:99444387 n11:HQC n12:5288581 n13:4450715 n14:DB07916
n3:IUPAC-Name
n4:271B4BE6-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4BEC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4BEB-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4BE8-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4BE9-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4BEA-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4BE4-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4BE2-363D-11E5-9242-09173F13E4C5 n4:271B4BE5-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4BE3-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4BF2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4BF3-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4BED-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4BEE-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4BF0-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4BEF-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4BF1-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4BF8-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4BFA-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4BFB-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4BF7-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4BF6-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4BF9-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4BE7-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4BF4-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4BF5-363D-11E5-9242-09173F13E4C5